Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

CDC MMWR Recommendations for Acyclovir and Alternative Antiviral Dosing in Herpes Zoster

Immunocompromised Adult Dosing

  • The CDC MMWR recommends a body‑surface‑area–based oral acyclovir dose of 500 mg/m² every 8 hours for immunocompromised adults with herpes zoster, as an alternative to the fixed 800 mg five‑times‑daily regimen. 1
  • For severe or disseminated herpes zoster in immunocompromised adults, the CDC MMWR suggests an intravenous acyclovir dose of 500 mg/m² every 8 hours (alternative to 10 mg/kg) to achieve adequate plasma concentrations. 1

Pediatric Dosing (Children > 2 years, HIV‑infected)

  • The CDC MMWR advises oral acyclovir 20 mg/kg (maximum 800 mg per dose) four times daily for 7–10 days in HIV‑infected children, providing plasma levels comparable to adult therapeutic concentrations. 1
  • For severe disease in HIV‑infected children, the CDC MMWR recommends intravenous acyclovir 10 mg/kg every 8 hours for 10–14 days. 1
  • An alternative pediatric intravenous regimen endorsed by the CDC MMWR is 500 mg/m² IV every 8 hours for children older than 1 year. 1

Alternative Oral Antivirals

  • The CDC MMWR lists famciclovir 500 mg three times daily for 7–10 days as an equally effective option to acyclovir for herpes zoster, offering improved dosing convenience due to its longer intracellular half‑life. 1

Management of Acyclovir‑Resistant VZV

  • According to the CDC MMWR, foscarnet 40–60 mg/kg IV every 8 hours for 7–10 days is the treatment of choice for acyclovir‑resistant varicella‑zoster virus infection, which predominantly occurs in immunocompromised patients. 1
  • The Ophthalmology journal (2024) notes that higher doses of oral antivirals may be trialed before transitioning to foscarnet in cases of suspected acyclovir resistance. 2

Aciclovir Dosage for Herpes Zoster

Dosage by Population and Administration Route

  • For immunocompromised patients, including those with HIV, the recommended dosage is 800 mg orally 5 times a day for 7-10 days, with some experts basing dosage on body surface area: 500 mg/m² every 8 hours, according to the MMWR Recommendations and Reports 3, 4
  • For immunocompromised patients with severe or disseminated disease, the recommended intravenous dosage is 10 mg/kg every 8 hours for 7-10 days, or alternatively 500 mg/m² IV every 8 hours, as per the MMWR Recommendations and Reports 3, 4
  • For pediatric patients with HIV, the recommended oral dosage is 20 mg/kg (maximum 800 mg/dose) 4 times a day for 7-10 days, and for severe disease, the recommended intravenous dosage is 10 mg/kg every 8 hours for 10-14 days, according to the MMWR Recommendations and Reports 3, 4
  • For patients who require more convenient treatment regimens, famciclovir 500 mg 3 times a day for 7-10 days is an alternative, with comparable efficacy and better convenience, as recommended by the MMWR Recommendations and Reports 3, 4
  • In cases of aciclovir resistance, primarily in immunocompromised patients, foscarnet 40-60 mg/kg IV every 8 hours for 7-10 days is recommended, according to the MMWR Recommendations and Reports 3, 4